Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Brands Inc (NQ: TLRY )

1.871 +0.081 (+4.55%)
Streaming Delayed Price Updated: 1:23 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,662,093
Open 1.840
Bid (Size) 1.870 (527)
Ask (Size) 1.880 (1,118)
Prev. Close 1.790
Today's Range 1.810 - 1.880
52wk Range 1.600 - 3.400
Shares Outstanding 730,289,573
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tilray Will Quintuple Its Medical Marijuana Production In Germany With New Cultivation License
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Monday that its Germany cannabis cultivation facility, Aphria RX GmbH, has obtained the first new cannabis cultivation license issued under... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Is Castellum (CTM) Stock Moving Today?
Castellum stock is on the move Monday as CTM shares are volatile following an announced a strategic alliance with Krilla Kaleiwahea. 
Via InvestorPlace

Performance

YTD
-15.70%
-15.70%
1 Month
+12.73%
+12.73%
3 Month
+8.80%
+8.80%
6 Month
-7.81%
-7.81%
1 Year
+10.73%
+10.73%

More News

Read More
XPEV Stock Alert: XPeng Expands EV Relationship with Volkswagen
Via InvestorPlace
Why Is Richtech Robotics (RR) Stock Up 40% Today?
Via InvestorPlace
Is Tilray Brands Stock a Buy?
Via The Motley Fool
Tilray Stock Pops as Germany Grants It a Cultivation Green Light
Via InvestorPlace
What's Going On With Tilray Brands Stock Monday?
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations
From Tilray Brands, Inc.
Via GlobeNewswire
3 Cannabis Stocks to Buy Now: Q3 Edition
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Delaware Starts Prepping for Adult-Use Cannabis Market Launch
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
3 Meme Stocks to Buy for Multibagger Returns Before the End of 2024
Via InvestorPlace
SweetWater Brewing Launches New Rowdy Peach IPA in Collaboration With Atlanta United FC
From Tilray Brands, Inc.
Via GlobeNewswire
Aurora Cannabis Is Having a Good Year in 2024. Has It Turned Its Business Around?
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
3 Cannabis Stocks to Buy at a 52-Week Low in July
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Manitoba Harvest Hemp Foods and Brightseed® Introduce New Coffee and Chocolate Flavors in Organic Bioactive Fiber Supplement for Gut Health
From Tilray Brands, Inc.
Via GlobeNewswire
Cannabis Stocks: Canadian Companies Outperformed American Counterparts Last Week
Via Benzinga
Topics Cannabis
Exposures Cannabis
Canadian Cannabis LP Portfolio Popped 11% Last Week; Now +18% YTD
Via Talk Markets
Topics Cannabis
Exposures Cannabis
When Is Cannabis Giant Tilray Reporting Earnings And What Should Investors Expect?
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Cannabis Stocks That Could Grow Your Wealth
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Tilray Brands, Inc. to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on July 29, 2024
From Tilray Brands, Inc.
Via GlobeNewswire
New Study Shows High Use Of Medical Cannabis For Chronic Pain And Arthritis In Older Patients
Via Benzinga
Topics Cannabis
Exposures Cannabis
Leaked Documents: Czech Republic Plans To Set Up Legal Recreational Cannabis Market
Via Benzinga
Topics Cannabis
Exposures Cannabis
Canadian Cannabis LPs Doubled Performance Of American MSOs This Week
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The 3 Best Stocks to Buy for Q3 2024
Via InvestorPlace
The 3 Most Undervalued Cannabis Stocks to Buy in July 2024
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.